FOI2026/2076

For NHS Greater Manchester Integrated Care Board: Please limit this request to adult dermatology Advice and Guidance pathways commissioned or overseen by the ICB, and records for 1 April 2025 to 31 March 2026.

1. Please provide the pathway specification and recorded rules for converting Advice and Guidance to an outpatient referral, returning it to primary care, and telling patients whether they have joined a waiting list.
2. Please provide the existing ICB-held dashboard or evaluation showing requests converted to referrals, returned for further information or remaining unresolved, including definitions and elapsed-time measures where held.
3. Please provide the latest completed quality/safety audit or review of this pathway and its action plan, including any assessment of repeat requests or referrals after an initial return. I am requesting commissioner-held records, not a new patient-record exercise.

Please reply electronically, supplying tables in their existing spreadsheet/CSV format where held. I am requesting existing records, not a new investigation or identifiable personal information. Please distinguish information not held from a recorded zero. A direct link is fine for published information. If part would exceed the applicable cost limit or require an unreasonable search, please advise how to narrow it, prioritising the first two items. Please disclose the remaining material with any necessary redactions.

1. PDF documents were sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net
2. An excel document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net
3. NHS GM has not undertaken a formal quality / safety audit of this pathway to date. It has worked with providers (both primary care and providers of elective care) to implement safely and effectively as part of the wider roll out of A&G in GM.